These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1384524)

  • 61. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.
    Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H
    Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of hepatitis C virus antibodies in hospital personnel.
    Abb J
    Zentralbl Bakteriol; 1991 Jan; 274(4):543-7. PubMed ID: 1650558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV, HBV and HCV seropositivity in hemophiliacs.
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis.
    Chau KH; Dawson GJ; Mushahwar IK; Gutierrez RA; Johnson RG; Lesniewski RR; Mattsson L; Weiland O
    J Virol Methods; 1991 Dec; 35(3):343-52. PubMed ID: 1667792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7).
    Saito M; Hasegawa A; Kashiwakuma T; Kohara M; Sugi M; Miki K; Yamamoto T; Mori H; Ohta Y; Tanaka E
    Clin Chem; 1992 Dec; 38(12):2434-9. PubMed ID: 1281050
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Analytical study of the Abbott and Ortho tests for screening and confirmation of anti-HCV antibodies. Le groupe de Travail "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Janot C; Couroucé AM; Boudart D; Cotte C; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M; Mattlinger B
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):171-82. PubMed ID: 1384522
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serological response and detection of viraemia in acute hepatitis C virus infection.
    Dourakis S; Brown J; Kumar U; Karayiannis P; Kernoff P; Chiba J; Ohba H; Miyamura T; Saito I; Monjardino J
    J Hepatol; 1992 Mar; 14(2-3):370-6. PubMed ID: 1380025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped.
    Cunningham SJ; Cunningham R; Izmeth MG; Baker B; Hart CA
    Epidemiol Infect; 1994 Feb; 112(1):195-200. PubMed ID: 7509754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HCV core IgM and IgG antibodies in blood donors.
    Kapprell HP; Majnak A; Medgyesi GA; Szabó JE; Michel G; Albrecht M; Heyermann H; Hampl H; Troonen H
    Vox Sang; 1995; 68(1):57-8. PubMed ID: 7536991
    [No Abstract]   [Full Text] [Related]  

  • 75. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
    Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
    Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
    Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 78. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia.
    Farci P; London WT; Wong DC; Dawson GJ; Vallari DS; Engle R; Purcell RH
    J Infect Dis; 1992 Jun; 165(6):1006-11. PubMed ID: 1374781
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [No HCV seroconversion in hemophilia following substitution with virus-inactivated coagulation factor VIII and IX concentrates].
    Perret BA; Morell A; Bütler-Brunner E; Burckhardt JJ
    Schweiz Med Wochenschr; 1991 Nov; 121(44):1621-3. PubMed ID: 1658928
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.
    Vrielink H; van der Poel CL; Reesink HW; Zaaijer HL; Lelie PN
    Vox Sang; 1995; 68(1):55-6. PubMed ID: 7536990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.